Correlation Between Medicofarma Biotech and WIG 30

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medicofarma Biotech and WIG 30 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicofarma Biotech and WIG 30 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medicofarma Biotech SA and WIG 30, you can compare the effects of market volatilities on Medicofarma Biotech and WIG 30 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicofarma Biotech with a short position of WIG 30. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicofarma Biotech and WIG 30.

Diversification Opportunities for Medicofarma Biotech and WIG 30

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Medicofarma and WIG is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Medicofarma Biotech SA and WIG 30 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WIG 30 and Medicofarma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicofarma Biotech SA are associated (or correlated) with WIG 30. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WIG 30 has no effect on the direction of Medicofarma Biotech i.e., Medicofarma Biotech and WIG 30 go up and down completely randomly.
    Optimize

Pair Corralation between Medicofarma Biotech and WIG 30

Assuming the 90 days trading horizon Medicofarma Biotech SA is expected to under-perform the WIG 30. In addition to that, Medicofarma Biotech is 4.83 times more volatile than WIG 30. It trades about 0.0 of its total potential returns per unit of risk. WIG 30 is currently generating about 0.0 per unit of volatility. If you would invest  281,357  in WIG 30 on September 23, 2024 and sell it today you would lose (268.00) from holding WIG 30 or give up 0.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.45%
ValuesDaily Returns

Medicofarma Biotech SA  vs.  WIG 30

 Performance 
       Timeline  

Medicofarma Biotech and WIG 30 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medicofarma Biotech and WIG 30

The main advantage of trading using opposite Medicofarma Biotech and WIG 30 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicofarma Biotech position performs unexpectedly, WIG 30 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WIG 30 will offset losses from the drop in WIG 30's long position.
The idea behind Medicofarma Biotech SA and WIG 30 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.